F-star Delta Limited   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge United Kingdom (2016)
Status: Acquired by InvoX (2022)

Organization Overview

First Clinical Trial
2018
NCT03440437
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

F-star Beta Limited | F-star Delta Limited | F-star Therapeutics Limited